Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Radioligand Binding Assay from US Patent US20240199555: "APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HT7 RECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION"
Assay data:29 Active, 7 Activity ≤ 1 nM, 28 Activity ≤ 1 µM, 29 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
[3H]Dopamine ([3H]DA) Uptake Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:47 Active, 47 Activity ≤ 1 µM, 47 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
[3H]Dihydrotetrabenazine ([3H]DTBZ) Binding Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:49 Active, 18 Activity ≤ 1 µM, 53 Tested
[3H]DA and [3H]5-HT Uptake Assay from US Patent US11999676: "Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse"
Assay data:90 Active, 90 Activity ≤ 1 µM, 91 Tested
Competition Binding in Human 5-HT2A Receptor from US Patent US20240166639: "POTENT AND SELECTIVE COMPOUNDS AS SEROTONIN 1B RECEPTOR MODULATORS"
Assay data:12 Active, 5 Activity ≤ 1 µM, 17 Tested
Binding at Human Serotonin Receptors Competition Binding in Human 5-HT1B Receptor Assay from US Patent US20240166639: "POTENT AND SELECTIVE COMPOUNDS AS SEROTONIN 1B RECEPTOR MODULATORS"
Assay data:17 Active, 4 Activity ≤ 1 nM, 16 Activity ≤ 1 µM, 17 Tested
5-HT2A Receptor Binding Assay from US Patent US20240166618: "PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME"
Assay data:91 Active, 7 Activity ≤ 1 nM, 89 Activity ≤ 1 µM, 98 Tested
Homogeneous Time-Resolved Fluorescence (HTRF) cAMP Antagonist Assay from US Patent US11987588: "Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto"
Assay data:591 Active, 569 Activity ≤ 1 µM, 592 Tested
5-HT2C Receptor Binding Test from US Patent US11980598: "N-(2-(substituted-naphth-1-yl)ethyl) substituted amide compound, preparation and uses thereof"
Assay data:3 Active, 1 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 3 Tested
Inhibition Assays of Transporters (hSERT and rVMAT2) from US Patent US20240150372: "OXA-IBOGAINE ANALOGUES FOR TREATMENT OF SUBSTANCE USE DISORDERS"
Assay data:3 Active, 2 Activity ≤ 1 µM, 3 Tested
Affinity of the Compounds of the Present Invention for Dopamine D2 Receptors from US Patent US20240124456: "AZA-ERGOLINE DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF"
Assay data:32 Active, 1 Activity ≤ 1 nM, 29 Activity ≤ 1 µM, 32 Tested
assay on hold
Summary
Mu-Opioid Receptor Activity Assay from US Patent US20240092802: "MU-OPIOID RECEPTOR AGONISTS AND USES THEREFOR"
Assay data:68 Active, 18 Activity ≤ 1 µM, 77 Tested
5-HT2C Receptor Binding Inhibition Assay from US Patent US20240083872: "CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY"
Assay data:114 Active, 11 Activity ≤ 1 nM, 101 Activity ≤ 1 µM, 114 Tested
5-HT2A Receptor Binding Inhibition Assay from US Patent US20240083872: "CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY"
Assay data:126 Active, 12 Activity ≤ 1 nM, 118 Activity ≤ 1 µM, 126 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on